You have no items in your shopping cart.
Oncology
In this section you will find Therapeutics Diseases & Conditions Oncology market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
| Items 31 to 45 of 482 total | Page: |
Sort by
|
Triple Analysis: Leukemia, Angiogenesis and Cancer Vaccines
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More
Triple Analysis: Leukemia, Angiogenesis and Protein Kinase Inhibitors
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More
Triple Analysis: Leukemia, Angiogenesis and Antibodies
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More
Triple Analysis: Leukemia, Angiogenesis and Peptides
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). Learn More
Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Angiogenesis. Learn More
Triple Analysis: Lung Cancer, Melanoma and Angiogenesis
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Learn More
Triple Analysis: Lung Cancer, Pancreatic Cancer and Angiogenesis
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Learn More
Triple Analysis: Lung Cancer, Prostate Cancer and Angiogenesis
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Learn More
Triple Analysis: Lung Cancer, Apoptosis and Angiogenesis
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More
Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More
Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More
Triple Analysis: Lung Cancer, Angiogenesis and Antibodies
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More
Triple Analysis: Lung Cancer, Angiogenesis and Peptides
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). Learn More
Triple Analysis: Lymphoma, Melanoma and Angiogenesis
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Angiogenesis. Learn More
Triple Analysis: Lymphoma, Pancreatic Cancer and Angiogenesis
Published by BioSeeker Group on Sep 7th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Learn More
| Items 31 to 45 of 482 total | Page: |
|
Sort by
|